Annual Report 2022 | STADA
Investor Relations | STADA
Annual General Meeting 2020 - Investor Relations | STADA
Press release : STADA further grows its European Consumer Healthcare portfolio by ... | Presseportal
Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is Improving
Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
Investor Relations | STADA
Investor Relations | STADA
Nidda Healthcare GmbH - Investor Relations
STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG
Financial Reports - Investor Relations | STADA
Ad hoc Releases - Stock - Investor Relations | STADA
Hemofarm - News - STADA Health Report: 81 percent of Europeans are open towards genetic testing
Corporate Presentation Investor Relations, May 2015
STADA shows resilience with double-digit growth in 2020 | STADA
Hemofarm - News - STADA's 2021 above-market development strengthens base for further growth, especially in Consumer Healthcare and Specialty
Press release: Zuellig Pharma becomes STADA Philippines' exclusive distribution partner | Presseportal
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Persona che tiene il cellulare con il logo della società tedesca Stada Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a fuoco sul display del telefono Foto stock -
STADA's excellent results in H1 2023 | STADA
IR Contact - Investor Relations | STADA
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Stocks
STADA diventa uno dei principali player del settore farmaceutico
